Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Scientist Paired with Cardiff MP to Share Insights on Cell Therapy, Science and Policy-Making

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Dr. Michelle Janas from GE Healthcare Life Sciences visited Jenny Willott MP at the House of Commons for a “Week in Westminster” as part of a unique ‘pairing’ scheme run by the Royal Society.

Dr. Janas is a Lead Scientist at GE Healthcare’s laboratories in Cardiff, Wales, where she is part of the team pioneering new technologies for cell therapy.  During her visit, she shadowed Ms Willott MP to learn about her work.  She also attended a House of Commons Science and Technology Committee meeting and Prime Minister’s Question Time, and met with Professor Sir John Beddington, Government Chief Scientific Advisor.  The visit provided Dr. Janas with a behind-the-scenes insight into how science policy is formed as well as an understanding of the working life of an MP.  Under the pairing scheme, Ms Willott will make a reciprocal visit to GE Healthcare.
 
Cell therapy, the use of cells to replace damaged tissue or treat disease, has the potential to help millions of patients suffering from life-threatening and life-limiting diseases like cancer and heart disease. Very much at the cutting edge of medicine, the UK Government recently announced a £50m investment into a new cell therapy technology innovation centre. GE Healthcare has established a global Centre of Excellence for Cell Technology Research at its facility in Cardiff, Wales.
 
Dr. Janas said: “I believe scientists have a role to play in helping to make innovations like cell therapy a reality through engagement with politicians and policy makers. It is exciting to be sharing my scientific experience with Ms Willott MP and I’m keen to further my understanding of how science policy is developed and communicated to the wider community.”
 
Jenny Willott MP said: “From participating in the scheme before, I know how rewarding and helpful it is to gain a different perspective.  I look forward to learning about Dr. Janas’ work on cell therapy at her lab in Cardiff. I hope I will get a better understanding of how politics and research together can realise the potential of these new technologies to bring real benefits to patients.”
 
Sir Paul Nurse, President of the Royal Society said:  “We live in a world facing increasing challenges that can only be addressed with a clear understanding of science.  From climate change to influenza outbreaks, GM food to nuclear power, our MPs have to make decisions about complex issues that will affect the lives of all those in the UK and, in many cases, more widely throughout the world.  This means that MPs and scientists have a responsibility to engage with each other to get the best possible scientific advice into public policy making.”
 
The Royal Society’s MP-Scientist pairing scheme aims to build bridges between parliamentarians and some of the best scientists in the UK. It is an opportunity for MPs to become better informed about science issues and for scientists to understand how they can influence science policy. Over 200 pairs of scientists and MPs have taken part in the scheme since it was launched in 2001.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Acquire Biosafe
Acquisition will develop integrated cell therapy and regenerative medicine offering to enable development and patient access to innovative life-saving therapies.
Saturday, July 16, 2016
GE Healthcare Investing in Cures for Cancer
GE’s acquisition of Biosafe Group SA further develops integrated cell therapy and regenerative medicine enabling development and patient access to innovative therapies.
Wednesday, July 13, 2016
GE Healthcare Expands European Capabilities
Expansion will see large volume sterile liquid handling capacity doubled.
Tuesday, April 12, 2016
BeiGene Selects GE’s FlexFactory™ Biomanufacturing Platform
Facility will manufacture biologics for clinical trials.
Wednesday, December 16, 2015
GE Healthcare Licenses CRISPR Gene Engineering Technology Patents
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Tuesday, December 09, 2014
GE Licenses CRISPR Gene Engineering Technology Patents From Broad Institute
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Thursday, December 04, 2014
GE Healthcare and Takeda Join Forces
This alliance is key to enabling the early development of therapeutic drugs through the use of a minimally invasive diagnostic technology.
Thursday, November 13, 2014
GE Healthcare to Collaborate with GlaxoSmithKline on Commercial Oncology Testing
The collaboration aims to improve access to diagnostic testing for cancer patients by establishing a network of clinical laboratories to identify genetic mutations associated with different tumour types.
Tuesday, September 30, 2014
GE Healthcare Life Sciences and Promosome Sign Licensing Agreement
Innovative mammalian cell line development technologies that show promise for increasing manufacturing efficiency of vital biopharmaceuticals.
Tuesday, April 29, 2014
GE Acquires Strategic Assets from Thermo
GE to acquire cell culture media and sera, gene modulation and magnetic beads businesses.
Monday, January 06, 2014
GE Healthcare Acquires Unisyn Medical Technologies’ Transactional Business
The proprietary products and services from Unisyn will be integrated into GE Healthcare’s Global Services organization.
Thursday, May 30, 2013
Winners of GE Healthcare 2012 Cell Imaging Competition Announced
Stunning cellular images to light up Times Square, New York.
Thursday, February 28, 2013
GE Healthcare Launches Modular Biopharmaceutical Factory, KUBio
Innovative approach will save biopharmaceutical manufacturers time and money.
Tuesday, January 15, 2013
iBio, Inc. and GE Healthcare Form New Global Alliance
Companies to commercialize plant-based technologies for biopharmaceutical and vaccine manufacture.
Thursday, December 27, 2012
GE Healthcare’s 2012 Cell Imaging Competition - Voting Opens to Celebrate Art, Science and Discovery
Competition features both high-content analysis and high- and super-resolution microscopy cell images for the first time.
Thursday, November 22, 2012
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Protein Boosts Rice Yield by 54%
Over-expression of a natural protein in rice plants led to a 54% increase in crop yield and 40% increase in nitrogen-use efficiency.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Soil Nitrogen Age Important for Precision Agriculture
Calculating the age of nitrogen in corn and soybean fields could lead to improved fertilizer application techniques.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!